Patent 7976853 was granted and assigned to Takeda Pharmaceutical Company on July, 2011 by the United States Patent and Trademark Office.
The present invention provides a production method of a preparation coated with pioglitazone hydrochloride, which is useful as a therapeutic agent for diabetes and the like, and which is superior in the characteristics of the preparation such as dissolution property of pioglitazone hydrochloride.